APBI 2016

Material & Methods – Patient features

n=217 pts.

Rec (%)

Hormonal therapy:

Prim (%)



- Yes - No

38.7 47.5 13.8

65.0 32.7

- Unknown

2.3

 Chemotherapy: - Yes

35.0 63.1

19.8 78.8

- No

- Unknown

1.8

1.4

Trastuzumab: -Yes



1.4

1.8

No

98.6

98.2

 Breast conserving surgery

100

100

 External beam RT

100

0

(Median RT dose (Gy):56 [30 – 69.6)]

 (Salvage)-Brachytherapy

0

100

University Hospital Erlangen